Literature DB >> 8703122

Microsatellite instability in IVS3 of murine c-fes gene: tumor-associated rearrangement and mammalian divergence.

L Volpi1, A Beghini, D Rossi, L Larizza.   

Abstract

The murine lymphomacrophage hybrids ESb, EbF1, EbF2-c4, which express c-fes constitutively, were found by Southern analysis to bear a c-fes deletion of almost 100 bp. The deleted allele was transmitted to the metastatic hybrids by their nonexpressing, poorly metastatic T-lymphoma progenitor Eb, which also has a structurally normal c-fes allele. PCR amplification and sequencing of fes cDNA spanning exons 3-5, where the deletion mapped, ruled out any involvement of coding sequences in the rearrangement. PCR amplification of the as yet unsequenced murine c-fes IVS3 and IVS4 showed they are about 50% longer than their human and feline homologs. Sequencing of IVS4 showed no difference between tumor and control DNA. Sequencing of part of the approximately 2600-bp IVS3 was guided by the restriction analysis of PCR products from control and hybrid DNAs. This showed that differences from the control appeared to be mainly located in the 900-bp HindIII-EcoRI fragment, localized in the middle of IVS3. As all three hybrids had the same restriction map, this fragment was sequenced in one of them (ESb). A run of >200 CA repeats was found in control DNA, and a reduction in the CAn microsatellite accounted for most of the c-fes deletion in the ESb hybrid. Interestingly, the 50% reduction in the size of human and feline c-fes IVS3 as compared with the murine homolog is mostly due to contraction of the same microsatellite.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703122     DOI: 10.1007/s003359900205

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  15 in total

1.  Expression pattern of c-fes oncogene mRNA in human myeloid cells.

Authors:  L Lanfrancone; P Mannoni; M J Pebusque; A Carè; C Peschle; F Grignani; P G Pelicci
Journal:  Int J Cancer Suppl       Date:  1989

2.  Characterization of human and mouse c-fes cDNA clones and identification of the 5' end of the gene.

Authors:  M Alcalay; F Antolini; W J Van de Ven; L Lanfrancone; F Grignani; P G Pelicci
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

Review 3.  Microsatellite instability: marker of a mutator phenotype in cancer.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  1994-10-01       Impact factor: 12.701

4.  Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells.

Authors:  R A Feldman; J L Gabrilove; J P Tam; M A Moore; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

5.  Structure of the feline c-fes/fps proto-oncogene: genesis of a retroviral oncogene.

Authors:  A J Roebroek; J A Schalken; C Onnekink; H P Bloemers; W J Van de Ven
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

6.  Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.

Authors:  M Jücker; A J Roebroek; J Mautner; K Koch; D Eick; V Diehl; W J Van de Ven; H Tesch
Journal:  Oncogene       Date:  1992-05       Impact factor: 9.867

7.  Activation of c-fos and c-fes in metastatic lympho-macrophage hybrids.

Authors:  S Fumagalli; L Volpi; D Rossi; L Larizza
Journal:  Int J Cancer       Date:  1992-09-30       Impact factor: 7.396

8.  Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.

Authors:  R Parsons; L L Myeroff; B Liu; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

9.  c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3.

Authors:  Y Hanazono; S Chiba; K Sasaki; H Mano; A Miyajima; K Arai; Y Yazaki; H Hirai
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

10.  Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage.

Authors:  L Larizza; V Schirrmacher; E Pflüger
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.